Last update 21 Nov 2024

pNGVL4aCRTE6E7L2

Overview

Basic Info

Drug Type
DNA vaccine, Prophylactic vaccine
Synonyms
pNGVL4aCRTE6E7L2 plasmid DNA
Target-
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsInfectious DiseasesUrogenital Diseases+ [1]
Active Indication
Atypical Squamous Cells of the CervixSquamous Intraepithelial LesionsHuman Papillomavirus Infection
Inactive Indication-
Originator Organization
The University of Alabama at BirminghamThe University of Alabama at Birmingham
Active Organization
The Johns Hopkins UniversityThe Johns Hopkins UniversityPapivax Biotech, Inc.The University of Alabama at BirminghamThe University of Alabama at Birmingham
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with pNGVL4aCRTE6E7L2
NCT03913117 / RecruitingPhase 1IIT
Phase I Clinical Trial Assessing the Safety and Feasibility of Intramuscular pNGVL4aCRTE6E7L2 and TA-CIN Administration for the Treatment of Patients With Persistent HPV16+ ASC-US or LSIL
100 Clinical Results associated with pNGVL4aCRTE6E7L2
Login to view more data
100 Translational Medicine associated with pNGVL4aCRTE6E7L2
Login to view more data
100 Patents (Medical) associated with pNGVL4aCRTE6E7L2
Login to view more data
100 Deals associated with pNGVL4aCRTE6E7L2
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Atypical Squamous Cells of the CervixPhase 1
US
The Johns Hopkins UniversityThe Johns Hopkins University
10 Jul 2023
Atypical Squamous Cells of the CervixPhase 1
US
The University of Alabama at BirminghamThe University of Alabama at Birmingham
10 Jul 2023
Squamous Intraepithelial LesionsPhase 1
US
The University of Alabama at BirminghamThe University of Alabama at Birmingham
10 Jul 2023
Squamous Intraepithelial LesionsPhase 1
US
The Johns Hopkins UniversityThe Johns Hopkins University
10 Jul 2023
Human Papillomavirus InfectionPhase 1-
The University of Alabama at BirminghamThe University of Alabama at Birmingham
-
Human Papillomavirus InfectionPhase 1-
Papivax Biotech, Inc.
-
Human Papillomavirus InfectionPhase 1-
The Johns Hopkins UniversityThe Johns Hopkins University
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free